Cargando…
Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG)
PURPOSE: In 2008, the first gynecological cancer centres were certified by the German Cancer Society (DKG). Guideline-based quality Indicators (QIs) are a core element of the certification process. These QI are defined to assess the quality of care within the centres and can serve to measure the imp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587177/ https://www.ncbi.nlm.nih.gov/pubmed/37452203 http://dx.doi.org/10.1007/s00432-023-05132-z |
_version_ | 1785123303496613888 |
---|---|
author | Stuebs, Frederik A. Beckmann, Matthias W. Fehm, Tanja Dannecker, Christian Follmann, Markus Langer, Thomas Wesselmann, Simone |
author_facet | Stuebs, Frederik A. Beckmann, Matthias W. Fehm, Tanja Dannecker, Christian Follmann, Markus Langer, Thomas Wesselmann, Simone |
author_sort | Stuebs, Frederik A. |
collection | PubMed |
description | PURPOSE: In 2008, the first gynecological cancer centres were certified by the German Cancer Society (DKG). Guideline-based quality Indicators (QIs) are a core element of the certification process. These QI are defined to assess the quality of care within the centres and can serve to measure the implementation of guideline recommendation. This article aims to give an overview of the developing and updating process of guideline based-QIs for women with cervical cancer and presents the QI results from the certified gynaecological cancer centres. METHODS: The QIs are derived in a multiple step review process and then implemented in the certification data sheet of the certified centres. The first set of QIs created in 2014 was revised in the update process of the S3-Guideline in 2020. QIs are based on strong recommendations of the evidence-based “Guideline for patients with Cervical Carcinoma” (registry-number: 032/033OL). RESULTS: In total, there are nine guideline-based QIs for cervical cancer. Four QIs are part of the certification process. In the treatment year 2020, 3.522 cases of cervical cancer were treated in 169 centers. The target values for the four QIs were met in at least 95% of the certified centers. In the guideline update in 2020, a new QI was added to the set of QIs “Complete pathological report on conization findings” and the QI “Exenteration” was removed. CONCLUSIONS: QIs derived from strong recommendations of a guideline are an important tool to make essential parts of patient’s care measurable and enable the centers to draw consequences in process optimization. Over the years, the number of certified centers has grown, and the quality was improved. The certification systems is under constant revision to further improve patient’s care in the future, based on the results of the QI re-evaluation. |
format | Online Article Text |
id | pubmed-10587177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105871772023-10-21 Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) Stuebs, Frederik A. Beckmann, Matthias W. Fehm, Tanja Dannecker, Christian Follmann, Markus Langer, Thomas Wesselmann, Simone J Cancer Res Clin Oncol Research PURPOSE: In 2008, the first gynecological cancer centres were certified by the German Cancer Society (DKG). Guideline-based quality Indicators (QIs) are a core element of the certification process. These QI are defined to assess the quality of care within the centres and can serve to measure the implementation of guideline recommendation. This article aims to give an overview of the developing and updating process of guideline based-QIs for women with cervical cancer and presents the QI results from the certified gynaecological cancer centres. METHODS: The QIs are derived in a multiple step review process and then implemented in the certification data sheet of the certified centres. The first set of QIs created in 2014 was revised in the update process of the S3-Guideline in 2020. QIs are based on strong recommendations of the evidence-based “Guideline for patients with Cervical Carcinoma” (registry-number: 032/033OL). RESULTS: In total, there are nine guideline-based QIs for cervical cancer. Four QIs are part of the certification process. In the treatment year 2020, 3.522 cases of cervical cancer were treated in 169 centers. The target values for the four QIs were met in at least 95% of the certified centers. In the guideline update in 2020, a new QI was added to the set of QIs “Complete pathological report on conization findings” and the QI “Exenteration” was removed. CONCLUSIONS: QIs derived from strong recommendations of a guideline are an important tool to make essential parts of patient’s care measurable and enable the centers to draw consequences in process optimization. Over the years, the number of certified centers has grown, and the quality was improved. The certification systems is under constant revision to further improve patient’s care in the future, based on the results of the QI re-evaluation. Springer Berlin Heidelberg 2023-07-15 2023 /pmc/articles/PMC10587177/ /pubmed/37452203 http://dx.doi.org/10.1007/s00432-023-05132-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Stuebs, Frederik A. Beckmann, Matthias W. Fehm, Tanja Dannecker, Christian Follmann, Markus Langer, Thomas Wesselmann, Simone Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) |
title | Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) |
title_full | Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) |
title_fullStr | Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) |
title_full_unstemmed | Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) |
title_short | Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) |
title_sort | implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the german cancer society (dkg) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587177/ https://www.ncbi.nlm.nih.gov/pubmed/37452203 http://dx.doi.org/10.1007/s00432-023-05132-z |
work_keys_str_mv | AT stuebsfrederika implementationandupdateofguidelinederivedqualityindicatorsforcervicalcanceringynecologicalcancercenterscertifiedbythegermancancersocietydkg AT beckmannmatthiasw implementationandupdateofguidelinederivedqualityindicatorsforcervicalcanceringynecologicalcancercenterscertifiedbythegermancancersocietydkg AT fehmtanja implementationandupdateofguidelinederivedqualityindicatorsforcervicalcanceringynecologicalcancercenterscertifiedbythegermancancersocietydkg AT danneckerchristian implementationandupdateofguidelinederivedqualityindicatorsforcervicalcanceringynecologicalcancercenterscertifiedbythegermancancersocietydkg AT follmannmarkus implementationandupdateofguidelinederivedqualityindicatorsforcervicalcanceringynecologicalcancercenterscertifiedbythegermancancersocietydkg AT langerthomas implementationandupdateofguidelinederivedqualityindicatorsforcervicalcanceringynecologicalcancercenterscertifiedbythegermancancersocietydkg AT wesselmannsimone implementationandupdateofguidelinederivedqualityindicatorsforcervicalcanceringynecologicalcancercenterscertifiedbythegermancancersocietydkg |